Transfusion

Werfen Completes Acquisition of Immucor, Inc.

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and […]

Echo Lumena® Implementation from Manual Gel

University of Maryland Capital Region Health Medical Center (former Prince George's Hospital) is located in Upper Marlboro, Maryland, USA. It is a nonprofit acute care teaching hospital and regional referral centre. The hospital is a Level II trauma centre, the […]

Automated C3d DAT Assay Now Available!

Streamline your workflow with Immucor’s new Automated C3d DAT Assay, available on the Echo Lumena®/Echo® (v2.0) and NEO Iris®/NEO® (v2.0). Immucor’s automated instruments allow you to set up a testing profile to perform the IgG DAT and C3d DAT at […]

See Beyond Limits with Fully Automated Titration Assays

We are excited to announce the release of our fully automated ABO and non-ABO titration assays! Besides the usual benefits of automation, these fully automated assays provide numerous advantages specifically: Efficiency: Automate a labour intensive manual process and receive a […]

ImmuLINK^® v2.0

A couple of editions ago we were excited to announce the launch of ImmuLINK v2.0! For those who are not familiar with ImmuLINK, it is Immucor’s software suite designed specifically to improve testing efficiency and traceability in the Blood Bank. […]